USPTO serial 79388948
SIR-ACTIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 21, 2025
- Examiner
- BUTLER, ANDREA P
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SIR-ACTIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew M. Smith
Andrew M. Smith Resonate IP, LLCP.O. Box 1650Bend, OR 97709United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; diagnostic preparations for science or research purposes; reagents for research purposes; diagnostic reagents for science or research purposes; diagnostic reagents for in vitro or in vivo use for biochemistry, clinical chemistry, microbiology and cellular biology; reagents for in vitro or in vivo use in laboratories, except for medical or veterinary use; fluorescent chemical preparations used as fluorescent markers for marking proteins in cells for scientific purposes; chemical preparations for marking biomolecules; biomolecules containing reagents intended for scientific research purposes; fluorescent chemical preparations for use in microscopy; fluorescent biomolecules for use in microscopy | ACTIVE | — |
| 005 | diagnostic agents for medical purposes; in-vitro diagnostic preparations for medical use; diagnostic kits containing chemical products in the nature of diagnostic agents, preparations, and substances for medical use; kits comprising diagnostic agents, preparations and substances used for diagnostic purposes and medical use; diagnostic test reagents for medical or veterinary use; diagnostic reagents for medical or veterinary use; biological and chemical reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents and contrast agents for medical use; contrast media for in-vivo imaging | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 5, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 5, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 26, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 7, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 7, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 22, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 6, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 5, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 5, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 5, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 5, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 17, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 29, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 29, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 2, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 1, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 16, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 12, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |